Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Malaysia
/
Pharmaceuticals & Biotech
Create a narrative
Pharmaceuticals & Biotech Malaysian Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Pharmaceuticals & Biotech Malaysian Investing Ideas
All companies
Popular
Undervalued
Overvalued
Duopharma Biotech Berhad
HA
Haha94
Community Contributor
Anticipate Expansion in Duopharma Biotech as Leadership Prepares for Transition
Duopharma Biotech Bhd (KLSE: DPHARMA, ticker 7148) Healthcare – Pharmaceuticals / Biotech Investment Review Recommendation: HOLD (Initiated) Key Metrics Company Overview Duopharma Biotech Bhd is a leading pharmaceutical manufacturer in Malaysia, involved in the research, development, manufacturing, and distribution of generic and specialty pharmaceutical products. Its operations span: Ethical Classic : General therapeutic generics (e.g., cardiovascular, anti-infectives) Ethical Specialty : Bio-similars for oncology, renal, and metabolic diseases Consumer Healthcare (CHC) : Notable OTC brands like Champs, Flavettes, and Uphamol As of 2025, it exports to multiple countries and operates from 3 GMP-certified manufacturing facilities.
View narrative
RM 1.68
FV
23.8% undervalued
intrinsic discount
8.58%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies